Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

about

Abelson kinase acts as a robust, multifunctional scaffold in regulating embryonic morphogenesis.

P2860

Q30008895-53A114F6-6088-4B79-A000-0966D913A53E

P2860

Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

Item

http://www.wikidata.org/entity/Q40314843

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Role of the C-terminal actin b ...... survival and drug resistance.

@en

type

Item

label

Role of the C-terminal actin b ...... survival and drug resistance.

@en

prefLabel

Role of the C-terminal actin b ...... survival and drug resistance.

@en

P1476

Role of the C-terminal actin b ...... d survival and drug resistance

@en

P2093

Thompson SE

http://www.w3.org/2001/XMLSchema#string

Underhill-Day N

http://www.w3.org/2001/XMLSchema#string

Xenaki D

http://www.w3.org/2001/XMLSchema#string

P2860

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase.

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis.

Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins

The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation

BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpoint.

P304

774-783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2005.05949.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Pierce

Anthony D Whetton

Penelope Jane Owen-Lynch

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7290321

http://www.w3.org/2001/XMLSchema#string

P698

16487179

http://www.w3.org/2001/XMLSchema#string

Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

about

P2860

P2860

Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698